Evidence map›Paper›PMID 38530112›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2024

Low-Carbohydrate Diet Score and Risk of Hepatocellular Carcinoma: Findings from a Prospective Cohort Study.

Yen Thi-Hai Pham, Aizhen Jin, Renwei Wang, Jaideep Behari, Woon-Puay Koh, Jian-Min Yuan, Hung N Luu

Open access · greenAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Yen Thi-Hai PhamUniversity of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania.ORCID 0009-0001-3235-2110
Aizhen JinHealthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.ORCID 0009-0004-5906-5711
Renwei WangUniversity of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania.ORCID 0000-0001-8871-7054
Jaideep BehariDivision of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.ORCID 0000-0001-8077-5137
Woon-Puay KohHealthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.ORCID 0000-0002-5674-6341
Jian-Min YuanUniversity of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania.ORCID 0000-0002-4620-3108
Hung N LuuUniversity of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania.ORCID 0000-0002-2172-1849
University of Pittsburgh · USAgency for Science, Technology and Research · SGNational University of Singapore · SGUniversity of Pittsburgh Medical Center · USUPMC Hillman Cancer Center · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
Pittsburgh Liver Research CenterP30DK120531 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DAVID A GELLER · 2019 to 2026
$10.9M
Harnessing human brain and liver microphysiological systems for testing therapeutics for metastatic melanomaU01TR002383 · NCATS · VANDERBILT UNIVERSITY · PI MURPHY, WILLIAM L., TAYLOR, D. LANSING · 2018 to 2022
$7.6M
Prospective studies of cancer etiology and prevention in Shanghai and SingaporeR01CA144034 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YUAN, JIAN-MIN · 2010 to 2014
$7.0M
Cancer epidemiology cohorts in Shanghai and Singapore UM1CA182876 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YUAN, JIAN-MIN · 2014 to 2018
$4.3M
Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health OutcomesR01CA255809 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BEHARI, JAIDEEP, YUAN, JIAN-MIN · 2021 to 2025
$3.7M
Translational Research Training in Cancer Prevention and ControlT32CA186873 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Kathryn H. Schmitz, Jian-Min Yuan · 2014 to 2026
$2.7M
A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver diseaseUH3TR003289 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BEHARI, JAIDEEP, SOTO-GUTIERREZ, ALEJANDRO · 2022 to 2024
$2.3M
Alcoholic Hepatitis Consortia: an intramural/extramural collaboration to unravel genetic determinantsU01AA026264 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI BATALLER, RAMON, NAGY, LAURA E. · 2017 to 2022
$2.0M
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 7/9U01AA026978 · NIAAA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BEHARI, JAIDEEP · 2018 to 2022
$1.8M
Personalization of graphical models using multi-omics data for subtype discovery and prognosisU01CA274573 · NCI · AUBURN UNIVERSITY AT AUBURN · PI LUU, HUNG N, NGUYEN, TIN C · 2023 to 2025
$1.4M
Hillman Cancer Center, Medical Center, University of Pittsburgh (HCC)National Institutes of Health (NIH) 4UH3TR003289National Institutes of Health (NIH) T32CA186873National Institutes of Health (NIH) U01CA274573-01National Medical Research Council (NMRC) CSA-SI (MOH-000434)NCATS NIH HHS U01 TR002383NCATS NIH HHS UH3 TR003289NCI NIH HHS P30 CA047904NCI NIH HHS R01 CA144034NCI NIH HHS R01 CA255809NCI NIH HHS T32 CA186873NCI NIH HHS U01 CA274573NCI NIH HHS UM1 CA182876NIAAA NIH HHS U01 AA026264NIAAA NIH HHS U01 AA026978NIDDK NIH HHS P30 DK120531
6 · The paper itself

Abstract

Limited data are reported on the association between low-carbohydrate diet (LCD) score, a comprehensive measure of dietary pattern according to sources of carbohydrate, fat, and protein, and risk of hepatocellular carcinoma (HCC). We evaluated this score with HCC risk in the Singapore Chinese Health Study, a prospective cohort of 63,275 middle-aged and elderly Chinese living in Singapore and recruited during 1993-1998 period. LCD scores were derived from the semi-quantitative food frequency questionnaire at baseline. A nested case-control study involved 197 HCC cases and 465 controls was also constructed among 28,346 participants who provided blood samples. Cox proportional hazard regression method was used to calculate HRs and 95% confidence intervals (CI) for HCC with different levels of LCD scores. Conditional logistic regression was performed for the case-control study analysis. After 17.6 years of follow-up with 819,573 person-years, 561 participants developed primary HCC. Although there was a null association between total LCD score and HCC risk (HRper-SD increment = 1.07; 95% CI, 0.98-1.16; Ptrend = 0.06), there was a positive association between animal-based LCD and the risk of HCC (HRper-SD increment = 1.11; 95% CI, 1.02-1.21; Ptrend = 0.01). Furthermore, this association was present in both HBsAg-negative and HBsAg-positive individuals in the case-control study. In stratified analysis for the entire cohort, this positive association was only present in those who consumed alcoholic beverages monthly or less frequent but not in weekly or daily drinker (Pinteraction = 0.79). In summary, a diet with lower carbohydrate, higher animal fat and protein was significantly associated with higher risk of HCC among Chinese Singaporeans. PREVENTION RELEVANCE: In a large cohort study of more than 63,000 Chinese Singaporeans, we found that a diet with lower carbohydrate and higher animal fat and protein was associated with increased risk of HCC, suggesting that dietary modification could be an effective strategy in primary prevention to reduce the HCC burden.

Indexed as

Carcinoma, HepatocellularDiet, Carbohydrate-RestrictedLiver NeoplasmsAgedCase-Control StudiesCohort StudiesFemaleFollow-Up StudiesHumansMaleMiddle AgedProspective StudiesRisk FactorsSingaporeSurveys and Questionnaires

Identifiers

PMID38530112
PMCPMC11150087
OpenAlexW4393191499

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.